Viking Therapeutic (VKTX) PT Raised to $107 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Edward Nash raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $107.00 (from $106.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
